Schedule 13G ownership disclosure

BIORA THERAPEUTICS, INC.

Common Stock · CUSIP: 74319F404

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Context Capital Management, LLC

    Shares: 22,025.00 · Class: 0.5%

  • Michael S. Rosen

    Shares: 22,025.00 · Class: 0.5%

  • William D. Fertig

    Shares: 22,025.00 · Class: 0.5%

  • Charles E. Carnegie

    Shares: 22,025.00 · Class: 0.5%

  • Context Partners Master Fund, L.P.

    Shares: 22,025.00 · Class: 0.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001301396-25-000008
Form type
SCHEDULE 13G/A
Filer
BIORA THERAPEUTICS, INC.
CIK
CIK 1580063
Filed
Jul 10, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub